FDA grants Natural Cycles ' contraception app de novo marketing approval

The FDA announced today that it will allow marketing of Natural Cycles ’ contraception app in the US for pre-menopausal women aged 18 years and older. Previously approved in the UK and currently the subject of investigation by multiple regulatory agencies, the algorithm-driven app helps users track their menstrual cycle and informs them when they are most fertile.
Source: mobihealthnews - Category: Information Technology Source Type: news